info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Antidiuretic Drugs Companies

Antidiuretic drugs, also recognized as vasopressin analogs or antidiuretic hormone (ADH) analogs, are crucial medications utilized in treating conditions linked to excessive urination and fluid imbalance. These pharmaceuticals play an indispensable role in rectifying imbalances within the body's fluid levels, pivotal for maintaining optimal physiological functions. 

Antidiuretic Drugs Key Companies

 

Latest Antidiuretic Drugs Companies Update


Ferring B.V. (Netherlands) Received FDA approval for their nasal spray formulation of desmopressin acetate (DDAVP), extending their product portfolio and offering a convenient alternative for patients with diabetes insipidus.Launched educational campaigns and patient support programs to raise awareness about diabetes insipidus and improve disease management.


Novartis AG (Switzerland) Announced clinical trial results for their long-acting oral formulation of desmopressin, potentially offering improved convenience and reduced dosing frequency for patients with diabetes insipidus.Partnered with healthcare providers and patient advocacy groups to improve access to and affordability of antidiuretic drugs for individuals with diabetes insipidus.


Sanofi (France) Expanded their market reach for Minirin® (desmopressin acetate) through strategic partnerships with distributors in new emerging markets.Focused on research and development of next-generation antidiuretic drugs with targeted mechanisms of action for treating specific sub-types of diabetes insipidus.


Azelvan Pharmaceuticals (US) Received orphan drug designation from the FDA for their novel oral medication for central diabetes insipidus, opening opportunities for expedited development and market access.Collaborated with research institutions to explore the potential application of their antidiuretic drug for other rare medical conditions.


Avadel Pharmaceuticals (US) Introduced their Nocturna® (desmopressin acetate) tablets in a new tamper-evident blister pack, enhancing medication safety and compliance for patients with diabetes insipidus.Increased their online presence and patient engagement initiatives to provide educational resources and support for individuals managing diabetes insipidus.


List of Antidiuretic Drugs Key Companies in the Market



  • Par Sterile Products LLC (U.S.)

  • ADH Health (U.S.)

  • Azevan Pharmaceuticals Inc. (U.S.)

  • Teva Pharmaceutical Industries Ltd. (Israel)

  • Otsuka Holdings Co. Ltd (Japan)

  • Taj Pharmaceuticals Limited (India)

  • ALLERGAN (U.S.)


Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.